Amerisourcebergen
Health Care |
Pharmaceutical Companies
1300 Morris Dr, Chesterbrook, PA 19087
Recent News About Amerisourcebergen
View More
-
CHARLESTON – Cabell County and the City of Huntington will appeal last month’s federal verdict for the nation’s three largest drug distributors.
-
CHARLESTON – Two days after a federal judge ruled in favor of opioid distributors in a bellwether case, discussions about missed settlement opportunities continue.
-
CHARLESTON – After more than 11 months, a federal judge has ruled in favor of three drug distribution companies, saying their actions did not cause the opioid epidemic in Huntington and Cabell County.
-
Attorneys for the State of Washington and those defending three of the country’s biggest opioid pill distributors sparred this week over figures showing that drug ordering took a big jump around the year 2006.
-
CHARLESTON – The nation’s three largest drug distributors has filed a petition with the state Supreme Court questioning whether the state Mass Litigation Panel exceeded its authority by grouping more than 60 public nuisances opioid claims into one statewide complaint.
-
Inter-office memos in 2012 issued by officials of AmerisourceBergen, one of three distributors of opioid pills accused of irresponsibly flooding the drug market for profit and causing an overdose epidemic, used humor that some have described as cruel.
-
CHARLESTON – Attorneys for Cardinal Health and McKesson presented closing arguments in hope of convincing U.S. District Judge David Faber the distribution companies should not be held liable for any part in the opioid epidemic.
-
CHARLESTON – After a two-week break, plaintiff attorney Paul Farrell Jr. left no stone unturned as he presented the closing argument at the landmark federal opioid trial.
-
PHILADELPHIA – A proposed $26 billion settlement with opioid distributors and manufacturers which would benefit a group of states including Pennsylvania, has come under fire from Philadelphia District Attorney Larry Krasner – who feels the City’s compensation would be undervalued in the agreement, wants to continue litigating and has filed his own lawsuit seeking to preserve that right.
-
CHARLESTON – While a bipartisan group of state attorneys general have announced a tentative $26 billion settlement with four drug companies over their roles in the opioid epidemic, West Virginia will not be a part of the agreement.
-
CHARLESTON – During the last day of testimony in the landmark opioid trial, the defense’s argument shifted to Cabell County and the City of Huntington’s ability to effectively cover treatment programs through federal government grants and that the governments should be able to continue to do so.
-
CHARLESTON – An economist expert claims Cardinal Health had a due diligence system in place that was followed as designed, arguing earlier experts failed to note the system in place.
-
CHARLESTON – Tables turned as an expert witness for Cardinal Health had his professional reputation challenged during his testimony at the bellwether federal opioid trial.
-
CHARLESTON – As they began arguing their case, the three drug distributor defendants in the bellwether federal trial continued to rest blame on others for fueling the opioid epidemic.
-
CHARLESTON – Three of the nation’s largest pharmaceutical distribution companies pushed for a trial dismissal as the plaintiffs wrapped up their case at the bellwether federal opioid trial.
-
CHARLESTON – Testifying in the bellwether opioid trial, a expert witness on pharmaceutical-related abatement programs said he does not believe Cabell County has sufficient treatment programs to fight the opioid epidemic.
-
CHARLESTON – Testifying in the bellwether federal opioid trial, Huntington's former chief of police shared the pain he felt as watching his community be taken over by addiction.
-
CHARLESTON – At the federal trial against three major opioid distributors, a child welfare expert showed the impact of Opioid Use Disorder on children and the rising need – and lack – of proper resources.
-
CHARLESTON – Tension remained high in the courtroom of the landmark federal opioid trial as plaintiffs and defendants argued expert witness reports and testimonies.
-
CHARLESTON – As the landmark federal opioid trial entered its sixth week, tensions rose as defendants spent the day trying to discredit a report by a substance use disorder epidemiologist.
